On Monday, in the course of current trade, Shares of Hewlett-Packard Company (NYSE:HPQ), climbed 0.77%, and is now trading at $29.64.
Hewlett-Packard Company, will conduct a live audio webcast of its conference call to review its financial results for the third fiscal quarter ended Jul. 31, 2015.
The call is planned for Thursday, Aug. 20, at 5 p.m. ET / 2 p.m. PT.
Hewlett-Packard Company, together with its auxiliaries, provides products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses (SMBs), in addition to to the government, health, and education sectors worldwide.
During an Afternoon trade, Shares of Gogo Inc (NASDAQ:GOGO), climbed 1.26%, and is now trading at $16.89.
Gogo Inc., declared its financial results for the quarter ended June 30, 2015.
Gogo stated record quarterly revenue of $121.2 million, up 22% year-over-year. Service revenue raised 28% to $101.4 million, surpassing $100 million in a single quarter for the first time. Adjusted EBITDA raised $7.7 million to a record $10.8 million.
Gogo Inc., through its auxiliaries, provides aero communications services to the commercial and business aviation markets in the United States and internationally. The company operates three segments: Commercial Aviation North America, Commercial Aviation Rest of World, and Business Aviation.
Finally, Cytori Therapeutics Inc (NASDAQ:CYTX), gained 0.02% Monday.
Cytori Therapeutics, declared its second quarter financial results and offered updates on its corporate activity and clinical development.
Cytori continued to reduce its operating cash burn, spending about $4.8 million in the second quarter 2015, contrast to $9.2 million in Q2 2014. Second quarter 2015 net income allocable to common stockholders was $4.5 million (or a net loss of $8.7 million and $0.06 per share when not taking into account a non-cash charge of $13.1 million related to the change in fair value of warrant liabilities) contrast to $11.8 million (or $0.15 per share) for the same period in 2014. Cytori ended the second quarter of 2015 with $23.8 million of cash and cash equivalents.
Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy compriseing of a heterogeneous population of specialized cells, counting stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence, and thermal burns combined with radiation injury.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
